Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 12)
30 April 2026
Roche to present ophthalmology portfolio data at ARVO 2026
ARVO 2026: real‑world data show Vabysmo reduces retinal fluid in nAMD/DME; Susvimo enables sustained delivery with lower treatment burden; early vamikibart IL‑6 results; 45+ abstracts.
30 April 2026
Eli Lilly Q1 2026: Revenue up 56%, raises full‑year guidance
EPS jumped ~170% reported (~156% non‑GAAP); volume growth offset lower realized prices; FDA approved oral GLP‑1 Foundayo; positive Phase‑3 readouts; four acquisitions announced
30 April 2026
Merck & Co Q1 2026 Results — Sales Growth, Regulatory Approvals and Clinical Milestones
Q1 revenue $16.3B; KEYTRUDA $8.0B. GAAP loss $1.72/sh, non-GAAP loss $1.28/sh after $9.0B Cidara charge. Announced Terns acquisition; raised 2026 sales to $65.8-67.0B and non-GAAP EPS $5.04-5.16
29 April 2026
Genentech to present ophthalmology data at ARVO 2026
ARVO presentations: real-world Vabysmo data show retinal drying in wet AMD/DME; Susvimo demonstrates sustained delivery and reduced treatment burden; vamikibart shows early efficacy; >45 abstracts
29 April 2026
Novo Nordisk: Denecimig (Mim8) reduces annualised bleeding rate in haemophilia A regardless of inhibitor status
Denecimig (Mim8) cut annualised bleeding rates in haemophilia A (with/without inhibitors) in Phase 3 FRONTIER2 for once-monthly/weekly dosing; well tolerated, no thromboembolic events
29 April 2026
Evonik opens PEEK magnet‑wire lab in China
China lab develops PEEK rectangular magnet-wire for NEV motors: extrusion/coating, dimensional checks and reliability tests (BDV, PDIV, corona, oil-aging) to accelerate product development.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
29 April 2026
GSK Q1 2026 — Specialty Medicines Drive Growth
Q1 sales £7.6bn (+5% CER); Specialty Medicines £3.2bn (+14%). Core operating profit +10%, Core EPS +9%. Strong cash generation; 17p Q1 dividend. 2026 guidance and >£40bn 2031 target reaffirmed.
29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed
Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share
29 April 2026
AkzoNobel adds Iris CMX drone for precise aircraft coating inspections
Aerofleet adds a contact-sensor drone to pair with its visual-scan drone, capturing thickness, color and gloss. Dual-drone inspections take ~30 min, improving repaint timing and cutting costs.
29 April 2026
BASF’s industrial Cathedral and the ground it stands on
Integrated site captured synergies for decades—cutting costs, funding R&D—but gas-price shock in 2022 exposed systemic risk; response: restructure Ludwigshafen and expand production abroad.
29 April 2026
UPM Q1 2026: Strong start led by decarbonization solutions
Q1 sales €2,505m; comparable EBIT €274m (-5%); operating cash flow €89m; net debt €2,962m. Energy and biofuels strong. H1 comparable EBIT guidance €325–525m.
29 April 2026
Symrise Q1 2026: Organic sales -0.4%, full-year outlook reaffirmed
Strength in Food & Beverage, Pet Food, Fragrance; Taste, Nutrition & Health +1.7%, Scent & Care -3.4%. ONE SYM driving cost savings and reinvestment; APAC & Americas up, EMEA down
28 April 2026
Sinopec RIPP’s Sinoketol wins Gold at Geneva Invention Exhibition
New cyclohexanone route via cyclohexene esterification–hydrogenation: >99.95% single‑pass conversion, >8× equilibrium, −14% activation energy; waste −70%, CO₂ −38%; first commercial 2×200k t/yr unit
28 April 2026
Plastic Ingenuity adopts PureCycle PureFive recycled PP for coffee lids
Coffee lids now use 25-100% recycled polypropylene from a dissolution process; material retains virgin-like performance, has FDA food-contact clearance and GreenCircle certification.
28 April 2026
GSK: FDA grants priority review and Breakthrough Therapy for bepirovirsen
Phase III B-Well trials showed significantly higher functional cure rates and acceptable safety in chronic hepatitis B; drug is an antisense oligonucleotide; PDUFA date 26 Oct 2026
28 April 2026
MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China
Licensed process design and technical services for a continuous Trimellitic Anhydride (TMA) plant in China, cuts power, steam and water use; two-phase rollout, optional proprietary equipment.
28 April 2026
Novo Nordisk to present Wegovy and next‑generation obesity data at ECO 2026
Presenting 52 abstracts at ECO: data on semaglutide (injectable and oral), higher‑dose 7.2 mg, CagriSema combo, menopause effects, CV risk, weight‑loss timelines and real‑world outcomes.
28 April 2026
Evonik opens Asia PAthletic Center for sports polyamide innovation
Offers R&D, ISO/ASTM testing, pilot processing, 3D samples and application support for long‑chain polyamides (PEBAs) to accelerate sports and consumer product commercialization
28 April 2026
BASF and Nutrien partner to expand farmer access to low‑carbon biofuel markets
Farmers get agronomist support and digital tools to document low-carbon-intensity corn, connect with biorefineries, and access low-CI biofuel programs (e.g., Section 45Z).
28 April 2026
Elkem wins NOK 87m from Enova to scale biocarbon use in silicon production
Project (total NOK242m, 2026–28) will test industrial biocarbon across labs, pilots and five smelters to double biocarbon share (from ~25%) by 2030, potentially cutting up to 0.5 Mt CO2/yr
28 April 2026
trinamiX Mobile NIR: Material ID for Footwear & Textiles
Mobile NIR spectroscopy enables fast, on-site ID of shoe components and textile blends (incl. fiber ratios). Handheld + app + cloud improve sorting, recycling readiness and traceability.
28 April 2026
REMONDIS: Closing the Textile Loop
Joint initiatives improve textile collection, sorting and recycling; mechanical and chemical recycling needed for mixed fibres. EPR funding and eco-modulation to fund infrastructure and boost reuse.
28 April 2026
Air Liquide Q1 2026: growth and record investments
Q1 sales €6.8B (+3.4% ex-currency/energy). Gas & Services +2%; Healthcare +4%. Efficiencies €142M; operating cash flow +7%. Investments €1.5B, backlog €5.5B; DIG Airgas closed; +100bps margin target 2026.
28 April 2026
Boehringer Ingelheim’s survodutide achieves 16.6% weight loss in Phase III obesity trial
Trial met co-primary endpoints; 85.1% achieved ≥5% weight loss vs 38.8% placebo; weight loss mainly fat with reduced waist circumference; GI events were mild–moderate; MASH trials ongoing
28 April 2026
MAIRE’s Nextchem wins TMA licensing, process design and technical services contract in China with NX CONSER C5+
Continuous TMA production tech delivers power, steam and water savings. TMA feeds PVC plasticizers, coatings and polyester resins. Project in two phases with optional proprietary equipment supply.
28 April 2026
Clariant launches CATOFIN 1000 PDH catalyst
New PDH catalyst improves selectivity and productivity vs 310 series, extends lifetime, cuts tar precursors up to 20% to reduce fouling and works with CLARITY monitoring
28 April 2026
Sinopec's 12 Innovation Studios Join Petrochemical Industry Innovation Alliance
Company held an alliance exchange; emphasizes employee innovation studios - issued guidance, runs reviews; has 31 national and 182 group-level studios and will transfer innovations into production.
28 April 2026
Sinopec Deploys DeepSeek‑V4 Privately
DeepSeek‑V4 preview (1.6T params) was open‑sourced. The Flash model rivals top closed‑source systems in reasoning, is tuned for domestic chips, and was integrated into the group's AI platform.
27 April 2026
GSK efimosfermin granted FDA Breakthrough and EMA PRIME for MASH
Phase II data: once-monthly long-acting FGF21 candidate improved fibrosis and disease resolution in F2/F3, well tolerated; phase III underway and F4 trials planned; condition drives liver transplants
27 April 2026
Johnson Matthey chosen by Liquid Sunshine for Guangxi biomethanol plant
Planned biomethanol plant will use biomass gasification to produce 75,000 t/yr in phase 1; phase 2 could convert CO2 + electrolytic H2 to e‑methanol for e‑fuels, aiding marine decarbonisation.
← Previous
Next →
